Moderna, Inc. — Director's Dealing 2020

Oct 14, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Moderna, Inc. (MRNA)
CIK: 0001682852
Period of Report: 2020-10-12

Reporting Person: Hoge Stephen (President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-10-12	Common Stock	S	1009	$73.21	Disposed	1925521	Direct
2020-10-12	Common Stock	S	2735	$74.49	Disposed	1922786	Direct
2020-10-12	Common Stock	S	1256	$75.38	Disposed	1921530	Direct
2020-10-13	Common Stock	M	10000	$.99	Acquired	1931530	Direct
2020-10-13	Common Stock	S	10200	$75.78	Disposed	1921330	Direct
2020-10-13	Common Stock	S	1400	$77.82	Disposed	1919930	Direct
2020-10-13	Common Stock	S	2600	$78.40	Disposed	1917330	Direct
2020-10-13	Common Stock	S	700	$79.47	Disposed	1916630	Direct
2020-10-13	Common Stock	S	100	$80.39	Disposed	1916530	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-10-13	Stock Option (Right to Buy)	$.99	M	10000	Disposed	2023-08-19	Common Stock (10000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	4116	Indirect

Footnotes

F1: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on December 27, 2018, as amended on June 1, 2020.

F2: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $72.99 to $73.43. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F3: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $74.02 to $75.00. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F4: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $75.13 to $75.67 Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F5: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $75.77 to $76.63. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F6: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $77.17 to $78.16. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F7: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $78.22 to $78.92. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F8: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $79.29 to $79.64. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F9: This option is fully vested and exercisable.